(CIDRAP News) The Swiss drug company Roche has pledged to give the World Health Organization (WHO) enough doses of the antiviral drug oseltamivir (Tamiflu) to treat 3 million people, in the hope that it could help to stave off or delay an influenza pandemic.
(CIDRAP News) An early report on the seasonal influenza strains circulating in Europe reveals that some H1N1 viruses show signs of resistance to the antiviral drug oseltamivir, the European Centre for Disease Prevention and Control (ECDC) reported this week.
(CIDRAP News) The World Health Organization (WHO) today reported evidence of a less-than-satisfactory match between all three components of this season's influenza vaccine and the flu strains currently making people sick.
Editor's note: The second paragraph of this story was revised on Sep 24 to correct an error. On the basis of information from ProMED-mail (published by the International Society for Infectious Diseases), the original version said it was unusual for the southern hemisphere vaccine composition to be the same as the preceding northern hemisphere vaccine. A later ProMED-mail posting made clear that this is not unusual.
(CIDRAP News) A newly published analysis of oseltamivir-resistant influenza viruses collected last winter in Norway hints that they may increase an infected person's risk of pneumonia and sinus infections, but the small number of patients in the study means the finding is no more than a hint at this point.
(CIDRAP News) Because of a suboptimal match between this year's flu vaccine and circulating influenza B viruses, the World Health Organization (WHO) has recommended changing one of the three strains used in flu vaccines for the Northern Hemisphere next fall and winter.
(CIDRAP News) Pandemic H1N1 influenza activity is showing further signs of declining around the country but remains very widespread, the Centers for Disease Control and Prevention (CDC) reported today.
(CIDRAP News) Decreasing pandemic flu activity and growing supplies of vaccine offer a window of opportunity for people to protect themselves from the virus, especially if the nation experiences a third wave of infections, Thomas Frieden, MD, director of the US Centers for Disease Control and Prevention (CDC) said today.